Neuro3D SA

Newron

This biopharmaceutical company develops and commercialises therapies for patients with central and peripheral nervous system disorders, such as schizophrenia and Parkinson's disease.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

Neurosterix

This biopharmaceutical company develops allosteric modulator therapeutics to treat patients suffering from neurological and neuropsychiatric disorders, including schizophrenia and mood disorders.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

BrainZell

The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.

Neurocentrx Pharma Ltd

This biopharmaceutical company develops oral ketamine formulations to treat patients suffering from treatment-resistant mood disorders, neurodegenerative diseases, and complex pain conditions.

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.